kodycelne.pl
Zaloguj się Załóż darmowe konto

Kod 3004 90 · Pozycja 3004

Leki złożone z produktów zmieszanych lub niezmieszanych do celów terapeutycznych, lub profilaktycznych, pakowane w odmierzone dawki (włącznie z lekami podawanymi przez skórę) lub do postaci, lub w opakowania do sprzedaży detalicznej (z wył. zawierających antybiotyki, hormony lub steroidy stosowane jako hormony, alkaloidy, prowitaminy, witaminy, ich pochodne lub antymalaryczne substancje czynne)

Zobacz oficjalny tekst taryfy

Oficjalny tekst taryfy

Leki złożone z produktów zmieszanych lub niezmieszanych do celów terapeutycznych, lub profilaktycznych, pakowane w odmierzone dawki (włącznie z lekami podawanymi przez skórę) lub do postaci, lub w opakowania do sprzedaży detalicznej (z wył. zawierających antybiotyki, hormony lub steroidy stosowane jako hormony, alkaloidy, prowitaminy, witaminy, ich pochodne lub antymalaryczne substancje czynne)

Jak doszliśmy do tego kodu

  1. VI
  2. 30
  3. 3004
  4. 3004 90
Pokaż kroki

Wybierz kod 8-cyfrowy

Cło przywozowe dla poniższych kodów: 0.0%

Tylko jeden kod poniżej

3004 90 00

Leki złożone z produktów zmieszanych lub niezmieszanych do celów terapeutycznych, lub profilaktycznych, pakowane w odmierzone dawki (włącznie z lekami podawanymi przez skórę) lub do postaci, lub w opakowania do sprzedaży detalicznej (z wył. zawierających antybiotyki, hormony lub steroidy stosowane jako hormony, alkaloidy, prowitaminy, witaminy, ich pochodne lub antymalaryczne substancje czynne)

Bez cła

Ta podpozycja ma jeden kod 8-cyfrowy, więc to właśnie ten kod się stosuje.

Sprzedaż do Norwegii, Wielkiej Brytanii i USA

Cło naliczane przy przywozie.

Norwegia, Wielka Brytania i USA mają pod 6-cyfrowym kodem HS własne linie taryfowe. Stawki poniżej to wysokość cła, które organy celne tych krajów pobierają od towarów przywożonych z UE. Zanim oprzesz się na stawce, porównaj towar z opisem obowiązującym w danym kraju.

Norwegia

Bez cła

  • Ich linie taryfowe2 linie norweskie

30.04.9002 Containing narcotic drugs or psychotropic substances

Norweskie dane taryfowe sprawdzone 13 września 2026.

Wielka Brytania

Bez cła

  • Ich linie taryfowe1 linia brytyjska

3004 90 00 00 Other

W Irlandii Północnej obowiązują inne zasady.

Brytyjskie dane taryfowe sprawdzone 13 września 2026.

USA

0.0% lub 15.0%

Zależy od pytania

  • Ich linie taryfowe75 linii amerykańskich
  • Data zgłoszenia17 września 2026

3004.90.10.00 Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed

Zgłoszenie celne składa amerykański importer.

Amerykańskie dane taryfowe sprawdzone 16 września 2026.

Zobacz 2 norweskie linie

Sprzedaż do Norwegii

Norwegia dzieli kategorię 6-cyfrową po swojemu, więc to są jej własne linie pod nią, a nie ten kod UE. Sprawdź swój produkt przy ich brzmieniu; to, co pobiera norweska administracja celna, podajemy przy każdej linii.

  • 30.04.9002

    Containing narcotic drugs or psychotropic substances

    Cło zwykłe
    Bez cła
  • 30.04.9008

    Other

    Cło zwykłe
    Bez cła

Norweskie dane taryfowe w wersji 1.5/1.2, ostatnio sprawdzone 13 września 2026.

Zawiera dane norweskiej administracji celnej (data.toll.no), na licencji CC BY 4.0, dostosowane do wyświetlania.

Zobacz 1 brytyjską linię

Sprzedaż do Wielkiej Brytanii

Ile pobiera brytyjska administracja celna, gdy taki towar trafia do Wielkiej Brytanii.

  • 3004 90 00 00

    Other

    Cło zwykłe
    Bez cła

Te stawki obowiązują w Wielkiej Brytanii. Dla towarów wprowadzanych do Irlandii Północnej mogą obowiązywać inne zasady.

Brytyjskie dane taryfowe w wersji v4.0.1599, ostatnio sprawdzone 13 września 2026.

Zawiera informacje sektora publicznego na licencji Open Government Licence v3.0.

Źródło: UK Department for Business and Trade (data.api.trade.gov.uk).

Zobacz 75 amerykańskich linii

Sprzedaż do USA

To, co amerykański urząd celny pobiera, gdy tego rodzaju towary docierają z UE. Zgłoszenie składa i cło płaci amerykański importer.

  • 3004.90.10.00

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing antigens or hyaluronic acid or its sodium salt

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.01

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, For veterinary use

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.03

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing acyclovir or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.04

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing oseltamivir or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.05

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing valganciclovir, peramivir or their salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.06

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.07

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Containing fluconazole or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.08

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
Pokaż wszystkie linie (75)
  • 3004.90.92.09

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Containing metronidazole or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.10

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.11

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Containing trimethoprim and sulfamethoxazole or their salts

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.12

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.13

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing levofloxacin or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.14

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing linezolid or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.15

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.16

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing hydroxyurea or cyclophosphamide or their salts

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.17

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing tacrolimus or mycophenolate mofetil or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.18

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.19

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing metoprolol or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.20

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing amiodarone or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.21

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing diltiazem or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.22

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing hydralazine or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.23

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing enoxaparin or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.24

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing labetalol or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.25

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.26

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.27

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.28

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium dihydrate

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.29

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium (anhydrous)

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.30

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, For oral suspension

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.31

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.32

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, For oral suspension

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.33

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.34

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing O-Acetylsalicylic acid (Aspirin)

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.35

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing tramadol

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.36

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.37

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing dexmedetomidine, etomidate, midazolam, propofol or their salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.38

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing midazolam or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.39

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing phenytoin or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.40

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing propofol or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.41

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing levetiracetam, phenytoin or their salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.42

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing etomidate or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.43

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.44

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing lorazepam or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.45

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing olanzapine or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.46

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.47

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing rocuronium or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.48

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing succinylcholine or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.49

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.50

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Containing lidocaine or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.51

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.52

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Laxatives

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.53

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Antacids

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.54

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing famotidine or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.55

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing pantoprazole or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.56

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing ondansetron or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.57

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing glycopyrrolate or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.58

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing loperamide or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.60

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.61

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing furosemide and its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.62

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing hydrochlorothiazide or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.63

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.64

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing calcium gluconate

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.65

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing potassium chloride

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.66

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing sodium bicarbonate, in injection form

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.67

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.68

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Cough and cold preparations

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.69

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Containing diphenhydramine or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.70

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.71

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing albuterol sulfate

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.72

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing timolol maleate

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.73

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.74

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing heparin sodium or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.75

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing zoledronic acid or its salts

    Stawka podstawowa
    Free
    Z UE
    0.0% Oszacowane na podstawie opublikowanych amerykańskich środków Zastosowane amerykańskie pozycje: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.76

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other

    Stawka podstawowa
    Free
    Z UE
    0.0% lub 15.0% Zależy od pytania Zastosowane amerykańskie pozycje: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions

Obliczone dla zgłoszenia z dnia 17 września 2026.

Amerykańska taryfa celna 2026HTSRev19, ostatnio sprawdzona 16 września 2026.

Ostatnia zmiana, którą odnotowaliśmy: Revision 19 (2026), 16 września 2026.

Cła antydumpingowe i wyrównawcze, amerykańskie podatki importowe oraz opłaty celne nie są uwzględnione.

Powyższe opisy to amerykańskie teksty taryfowe, które USA publikuje wyłącznie po angielsku.

Źródło: amerykańska taryfa celna prowadzona przez US International Trade Commission (hts.usitc.gov), public domain, oraz środki opublikowane w Federal Register.

To jest szacunek pomocny w planowaniu, oparty na amerykańskiej taryfie celnej (wskazana rewizja) oraz środkach opublikowanych w Federal Register na wskazany dzień, dla przesyłki pochodzącej z UE. Nie jest to zgłoszenie celne, porada prawna ani opinia brokera celnego, a kodycelne.pl nie jest brokerem celnym licencjonowanym w Stanach Zjednoczonych. Klasyfikację, pochodzenie, wartość i należne cło przed zgłoszeniem potwierdza amerykański importer lub jego broker celny.

Pokazane tu stawki celne są szacunkowe, odczytane z oficjalnych danych taryfowych UE, Norwegii i Wielkiej Brytanii, wyłącznie dla orientacji. Aktualną stawkę sprawdź przed złożeniem zgłoszenia w przeglądarce taryfowej ISZTAR4, w bazie TARIC, u norweskiej administracji celnej albo w brytyjskim Online Trade Tariff. Stawka, którą zapłacisz, może też zależeć od kraju pochodzenia. To są wyłącznie podstawowe cła: VAT z tytułu przywozu, akcyza, cła antydumpingowe oraz środki ochronne i kontyngentowe nie są tu uwzględnione.